How eAccess Technology Can Benefit Specialty Pharmacy

Study: Survival Rate Has Steadily Increased for Adults with Relapsed Acute Lymphoblastic Leukemia Following Hematopoietic Cell Transplant

FDA Grants Regenerative Medicine Advanced Therapy, Fast Track Designations to Novel CAR T-Cell Therapy for Relapsed, Refractory B-cell Non-Hodgkin Lymphoma

Tip of the Week: Leadership and Power Should Be Acquired, Used Wisely